(S)-2-Allylpyrrolidine hydrochloride

Catalog No. :
ACMGVX730
CAS No. :
197230-28-7
Molecular Formula :
C7H14ClN
Molecular Weight :
147.65

IUPAC Name:(S)-2-allylpyrrolidine hydrochloride

(S)-2-Allylpyrrolidine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$172.00Login to see priceIn stockInquiry
250mg97%$230.00Login to see priceIn stockInquiry
500mg97%$385.00Login to see priceIn stockInquiry
1g97%$576.00Login to see priceIn stockInquiry
5g97%$1732.00Login to see priceIn stockInquiry
10g97%$2871.00Login to see priceIn stockInquiry
25g97%$6594.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-Allylpyrrolidine hydrochloride
IUPAC Name(S)-2-allylpyrrolidine hydrochloride
MDL No.MFCD17677185
Molecular FormulaC7H14ClN
Molecular Weight147.65
SMILESC=CC[C@@H]1CCCN1.Cl
InChI KeyNKBQANIGCPEPGT-OGFXRTJISA-N
Synonym(S)-2-allylpyrrolidine hydrochloride | (2r)-2-(2-propen-1-yl) pyrrolidine hydrochloride | 197230-28-7 | (2S)-2-prop-2-enylpyrrolidine | hydrochloride | 197230-31-2 | (S)-2-allylpyrrolidine HCl | SCHEMBL19285633 | WS-02284 | (2S)-2-(2-Propen-1-yl) pyrrolid
CAS No.197230-28-7
PubChem CID130367805

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMGVX730 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRNCS031 route compound structure diagram
    ACRNCS031399044-21-4 In Stock
  2. Then
  3. ACMGVX730 route product structure diagram
    ACMGVX730197230-28-7 In Stock
Inquiry

2. ACMGVX730 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMGVX730 route product structure diagram
    ACMGVX730197230-28-7 In Stock
Inquiry

Comments (0)